Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral

Transplant Proc. 1998 Nov;30(7):3521-3. doi: 10.1016/s0041-1345(98)01121-x.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Alanine Transaminase / blood
  • Blood Pressure
  • Cholesterol / blood
  • Creatinine / blood
  • Cyclosporine / administration & dosage*
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Dosage Forms
  • Dose-Response Relationship, Drug
  • Emulsions
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Uric Acid / blood

Substances

  • Dosage Forms
  • Emulsions
  • Immunosuppressive Agents
  • Uric Acid
  • Cyclosporine
  • Cholesterol
  • Creatinine
  • Alanine Transaminase